These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 19471187)
21. Quetiapine for schizophrenia. Med Lett Drugs Ther; 1997 Dec; 39(1016):117-8. PubMed ID: 9422044 [No Abstract] [Full Text] [Related]
22. Quetiapine improves sleep disturbance in acute bipolar disorder: a case series. Cohrs S; Gade K; Meier A; Jordan W; Falkai P; Rüther E; Rodenbeck A Pharmacopsychiatry; 2010 Jun; 43(4):154-5. PubMed ID: 20205075 [No Abstract] [Full Text] [Related]
23. New-onset diabetes mellitus associated with quetiapine. Procyshyn RM; Pande S; Tse G Can J Psychiatry; 2000 Sep; 45(7):668-9. PubMed ID: 11056833 [No Abstract] [Full Text] [Related]
24. Neuroleptic malignant-like syndrome induced with low-dose quetiapine treated with electroconvulsive therapy. Bora E; Saffet Gonul A; Akdeniz F; Vahip S Eur Psychiatry; 2003 Oct; 18(6):323. PubMed ID: 14611931 [No Abstract] [Full Text] [Related]
25. Weight gain in a patient with schizophrenia switched from quetiapine to amisulpride. Chen YY; Huang MC; Wu KC Psychiatry Clin Neurosci; 2008 Oct; 62(5):620-1. PubMed ID: 18950385 [No Abstract] [Full Text] [Related]
26. Alopecia associated with quetiapine. McLean RM; Harrison-Woolrych M Int Clin Psychopharmacol; 2007 Mar; 22(2):117-9. PubMed ID: 17293712 [TBL] [Abstract][Full Text] [Related]
27. Severe hyperlipidemia associated with olanzapine and quetiapine use. Carnahan RM; Reantaso AA; Teegarden BA; Pogue T Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359 [No Abstract] [Full Text] [Related]
28. Quetiapine-induced neutropenia in a bipolar patient with hepatocellular carcinoma. Tang HC; Chung KH Int J Psychiatry Med; 2014; 47(3):255-61. PubMed ID: 25084821 [TBL] [Abstract][Full Text] [Related]
29. Dose-dependent constipation with higher doses of quetiapine: a case series. Raedler TJ; Reimer J; Wiedemann K Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649 [TBL] [Abstract][Full Text] [Related]
32. Reversible withdrawal dyskinesia associated with quetiapine. Michaelides C; Thakore-James M; Durso R Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370 [No Abstract] [Full Text] [Related]
33. Restless legs syndrome following the combined use of quetiapine and paroxetine. Chou KJ; Chen PY; Huang MC Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):1139-40. PubMed ID: 20470847 [No Abstract] [Full Text] [Related]
34. Acneiform eruption and pruritus in a patient with quetiapine therapy. Kansal NK; Sharma M Skinmed; 2013; 11(5):317-8. PubMed ID: 24340477 [No Abstract] [Full Text] [Related]
35. Additional evidence of the abuse potential of quetiapine. Reeves RR; Brister JC South Med J; 2007 Aug; 100(8):834-6. PubMed ID: 17713313 [TBL] [Abstract][Full Text] [Related]
37. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387 [TBL] [Abstract][Full Text] [Related]
38. Adjunctive pregabalin to quetiapine in acute mania. Oulis P; Florakis AA; Tzanoulinos G; Papadimitriou GN Clin Neuropharmacol; 2009; 32(3):174. PubMed ID: 19483492 [No Abstract] [Full Text] [Related]